Expansion of the Candidozyma haemuli Species Complex - The Novel Species Candidozyma molenica, Isolated from Clinical and Environmental Sources
- PMID: 40888982
- PMCID: PMC12402029
- DOI: 10.1007/s11046-025-00985-z
Expansion of the Candidozyma haemuli Species Complex - The Novel Species Candidozyma molenica, Isolated from Clinical and Environmental Sources
Abstract
Due to the recent unprecedented global rise of Candidozyma auris in hospital environments the members of the Candidozyma haemuli species complex have raised significant interest of clinicians and researchers. Until the finding of C. auris, the species complex did not receive much attention as the known pathogenic species were only rarely encountered in hospitals and clinical diagnostic laboratories. During the past years several new species were described, such as Candidozyma khanbhai and Candidozyma vulturna, that were found to be of clinical importance. Here, we used phylogenetic and phenotypic analyses -including antifungal susceptibility testing- to characterize and describe a new and potentially clinically relevant yeast that we obtained from clinical specimen and flowers, representing the proposed novel species Candidozyma molenica.
Keywords: Candidozyma auris; Candidozyma haemuli species complex; Candidozyma khanbhai; Candidozyma vulturna; Emerging pathogen; Misidentification.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of interests: The authors have no relevant financial or non-financial interests to disclose. Ethical Approval: As a retrospective sample was used, and that non-traceable clinical information is given, which did not influence patient care and treatment or can reveal patient identity, the ethical approval has automatically been waived by the IRB.
Figures
References
-
- Daniel HM, Lachance MA, Kurtzman CP. On the reclassification of species assigned to Candida and other anamorphic ascomycetous yeast genera based on phylogenetic circumscription. Antonie Van Leeuwenhoek. 2014;106(1):67–84. 10.1007/s10482-014-0170-z. - PubMed
-
- Groenewald M, Hittinger CT, Bensch K, Opulente DA, Shen X-X, Li Y, Liu C, LaBella AL, Zhou X, Limtong S, Jindamorakot S, Gonçalves P, Robert V, Wolfe KH, Rosa CA, Boekhout T, Čadež N, Péter G, Sampaio JP, LachancM-A YAM, Daniel H-M, Takashima M, Boundy-Mills K, Libkind D, Aoki K, Sugita T, Rokas A, et al. A genome-informed higher rank classification of the biotechnologically important fungal subphylum Saccharomycotina. Stud Mycol. 2023;105:1–22. 10.3114/sim.2023.105.01. - PMC - PubMed
-
- Stavrou AA, Lackner M, Lass-Flörl C, Boekhout T. The changing spectrum of Saccharomycotina yeasts causing candidemia: phylogeny mirrors antifungal susceptibility patterns for azole drugs and amphothericin B. FEMS Yeast Res. 2019;19(4): foz037. 10.1093/femsyr/foz037. - PubMed
-
- de Jong AW, Hagen F. Attack, defend and persist: how the fungal pathogen Candida auris was able to emerge globally in healthcare environments. Mycopathologia. 2019;184(3):353–65. 10.1007/s11046-019-00351-w. - PubMed
-
- Forsberg K, Woodworth K, Walters M, Berkow EL, Jackson B, Chiller T, Vallabhaneni S. Candida auris: the recent emergence of a multidrug-resistant fungal pathogen. Med Mycol. 2019;57(1):1–12. 10.1093/mmy/myy054. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
